CVS Health (CVS) Tops Q2 EPS by 35c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $97.16 +2.28%
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Dividends declared per common share (in dollars per share): 0.43
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $1.81, $0.35 better than the analyst estimate of $1.46. Revenue for the quarter came in at $98.9 billion versus the consensus estimate of $94.73 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.30-$6.40, versus the consensus of $6.12.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
